162 related articles for article (PubMed ID: 12107114)
21. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
Lu Y; Boss JM; Hu SX; Xu HJ; Blanck G
J Immunol; 1996 Apr; 156(7):2495-502. PubMed ID: 8786310
[TBL] [Abstract][Full Text] [Related]
23. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
24. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate.
Lian RH; Kotwal GJ; Wellhausen SR; Hunt LA; Justus DE
J Immunol; 1996 Jul; 157(2):864-73. PubMed ID: 8752940
[TBL] [Abstract][Full Text] [Related]
25. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
Han Y; Zhou ZH; Ransohoff RM
J Immunol; 1999 Aug; 163(3):1435-40. PubMed ID: 10415044
[TBL] [Abstract][Full Text] [Related]
26. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
[TBL] [Abstract][Full Text] [Related]
27. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.
Zhou H; Su HS; Zhang X; Douhan J; Glimcher LH
J Immunol; 1997 May; 158(10):4741-9. PubMed ID: 9144488
[TBL] [Abstract][Full Text] [Related]
28. Capsaicin inhibits IFN-gamma-induced MHC class II expression by suppressing transcription of class II transactivator gene in murine peritoneal macrophages.
Mahmoud ME; Nikami H; Shiina T; Takewaki T; Shimizu Y
Int Immunopharmacol; 2010 Jan; 10(1):86-90. PubMed ID: 19825429
[TBL] [Abstract][Full Text] [Related]
29. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).
Xu Y; Wang L; Butticè G; Sengupta PK; Smith BD
J Biol Chem; 2004 Oct; 279(40):41319-32. PubMed ID: 15247294
[TBL] [Abstract][Full Text] [Related]
30. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.
Lee YJ; Benveniste EN
J Immunol; 1996 Aug; 157(4):1559-68. PubMed ID: 8759739
[TBL] [Abstract][Full Text] [Related]
31. Selective modulation of MHC class II chaperons by a novel IFN-γ-inducible class II transactivator variant in lung adenocarcinoma A549 cells.
Chiu BL; Li CH; Chang CC
Biochem Biophys Res Commun; 2013 Oct; 440(1):190-5. PubMed ID: 24055710
[TBL] [Abstract][Full Text] [Related]
32. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.
Chang CH; Fontes JD; Peterlin M; Flavell RA
J Exp Med; 1994 Oct; 180(4):1367-74. PubMed ID: 7931070
[TBL] [Abstract][Full Text] [Related]
33. Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.
Truax AD; Thakkar M; Greer SF
PLoS One; 2012; 7(4):e36013. PubMed ID: 22563434
[TBL] [Abstract][Full Text] [Related]
34. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1.
Zhong G; Fan T; Liu L
J Exp Med; 1999 Jun; 189(12):1931-8. PubMed ID: 10377188
[TBL] [Abstract][Full Text] [Related]
35. The IFN-gamma-induced transcriptional program of the CIITA gene is inhibited by statins.
Lee SJ; Qin H; Benveniste EN
Eur J Immunol; 2008 Aug; 38(8):2325-36. PubMed ID: 18601229
[TBL] [Abstract][Full Text] [Related]
36. MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.
Romero OA; Torres-Diz M; Pros E; Savola S; Gomez A; Moran S; Saez C; Iwakawa R; Villanueva A; Montuenga LM; Kohno T; Yokota J; Sanchez-Cespedes M
Cancer Discov; 2014 Mar; 4(3):292-303. PubMed ID: 24362264
[TBL] [Abstract][Full Text] [Related]
37. Proprotein convertase PACE4 is down-regulated by the basic helix-loop-helix transcription factor hASH-1 and MASH-1.
Yoshida I; Koide S; Hasegawa SI; Nakagawara A; Tsuji A; Matsuda Y
Biochem J; 2001 Dec; 360(Pt 3):683-9. PubMed ID: 11736660
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis for lack of expression of HLA class I antigens in human small-cell lung carcinoma cell lines.
Singal DP; Ye M; Qiu X
Int J Cancer; 1996 Nov; 68(5):629-36. PubMed ID: 8938146
[TBL] [Abstract][Full Text] [Related]
39. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression.
Chen H; Thiagalingam A; Chopra H; Borges MW; Feder JN; Nelkin BD; Baylin SB; Ball DW
Proc Natl Acad Sci U S A; 1997 May; 94(10):5355-60. PubMed ID: 9144241
[TBL] [Abstract][Full Text] [Related]
40. Cell-substratum interactions mediate oncogene-induced phenotype of lung cancer cells.
Barr LF; Campbell SE; Penno MB; Ball DW; Baylin SB
Cell Growth Differ; 1996 Sep; 7(9):1149-56. PubMed ID: 8877096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
